HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AIM-2: a novel tumor antigen is expressed and presented by human glioma cells.

Abstract
Antigen isolated from Immunoselected Melanoma-2 (AIM-2) was recently identified using melanoma-reactive CD8 T cells. AIM-2 antigen is expressed in a wide variety of tumor types, including neuroectodermal tumors, as well as breast, ovarian and colon carcinomas. In this study, we analyzed AIM-2 expression in glioblastoma multiforme (GBM) in primary cultured cells and established GBM cell lines. We found that the primary GBM cell lines expressed 88.4% and 93.0% of non-spliced and spliced AIM-2, respectively. Five out of seven of the established GBM cell lines expressed both non-spliced and spliced AIM-2. Furthermore, the C9 CTL clone, which is specific for AIM-2 peptide (RSDSGQQARY), efficiently recognized GBM tumor cells in an antigen-specific and HLA-A1 restricted manner. IFN-gamma treatment of the GBM tumor cells dramatically increased HLA-A1 expression levels and, consequently, increased CTL recognition of the treated tumor cells. More importantly, seven out of 12 HLA-A1 and AIM-2 positive patients from our dendritic cell clinical trial generated AIM-2 specific CTL activity in their PBMC after vaccinations. These data indicate that AIM-2 could be used as a tumor antigen target for monitoring vaccine trials or to develop antigen specific active immunotherapy for glioma patients.
AuthorsGentao Liu, John S Yu, Gang Zeng, Dong Yin, Dong Xie, Keith L Black, Han Ying
JournalJournal of immunotherapy (Hagerstown, Md. : 1997) (J Immunother) 2004 May-Jun Vol. 27 Issue 3 Pg. 220-6 ISSN: 1524-9557 [Print] United States
PMID15076139 (Publication Type: Journal Article)
Chemical References
  • AIM2 protein, human
  • Antigens, Neoplasm
  • DNA, Complementary
  • DNA-Binding Proteins
  • HLA-A1 Antigen
  • Nuclear Proteins
  • Peptides
  • RNA, Messenger
  • RNA
  • Interferon-gamma
Topics
  • Antigens, Neoplasm
  • Brain Neoplasms (metabolism)
  • Cell Line, Tumor
  • DNA, Complementary (metabolism)
  • DNA-Binding Proteins
  • Dendritic Cells (cytology, immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Glioblastoma (metabolism)
  • Glioma (metabolism)
  • HLA-A1 Antigen (chemistry)
  • Humans
  • Immunotherapy (methods)
  • Interferon-gamma (metabolism)
  • Leukocytes, Mononuclear (metabolism)
  • Nuclear Proteins (biosynthesis, chemistry)
  • Peptides (chemistry)
  • RNA (chemistry)
  • RNA, Messenger (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • T-Lymphocytes, Cytotoxic (metabolism)
  • Time Factors
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: